AliveCor launches clinical app with AI function for early detection of AFib to prevent stroke
AliveCor also raised a $30 million Series D round led by Omron Healthcare and Mayo Clinic.
McKesson, Blue Cross top digital health’s most trusted corporate VCs
Part II in our research examining which corporate venture capitalists you can trust and rely on.
The Human Algorithm: What AI Can’t Replace in Pharma Engagement
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.
Corporate ventures in life science are important, but generate mixed feelings
The shift in the stage of investment and where the perceived opportunities in biotech are have had a significant impact.